Intervention

Insulin Detemir

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting1

Common conditions7

Lead sponsors shown5

Clinical trials

5 shown

DETERMINE: Detemir vs NPHNCT05124457 · 2022-02-01

MeDiGes Study: Metformine Use in Gestational DiabetesNCT04222348 · 2016-10-26

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesNCT01420692 · 2010-06-01

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 DiabetesNCT00659165 · 2008-04-01

Lantus Versus Levemir Treat-To-TargetNCT00405418 · 2006-11-01

Common conditions

Diabetes Mellitus, Type 22 Diabetes Mellitus1 Diabetes, Gestational1 Gestational Diabetes1 Perinatal Disorder1 Puerperal Disorder1 Type 2 Diabetes Mellitus1

Leading sponsors

Ankara University1 Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud1 Sanofi1 University of California, Los Angeles1 University of New Mexico1

Trial status mix

COMPLETED3

RECRUITING1

UNKNOWN1

Phase mix

NA2

PHASE21

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.